Galvus (vildagliptin) improves glucose control
For people with type 2 diabetes and moderately elevated blood glucose levels, the medication vildagliptin, sold under the brand name Galvus, can produce long-term improvements in the functioning of the insulin-secreting beta cells in the pancreas along with better glucose control, researchers report.
“Improvement of glucose control, which was a known fact for vildagliptin, is paralleled, [...]